MedTrace Logo

Efficiency of Intercoat (Oxiplex/AP Gel)in Decreasing Intrauterine Adhesions

NCT01377779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-06-21

No results posted yet for this study

Summary

This is a prospective single blind randomized controlled pilot study was designed to investigate whether the biological barrier Intercoat (Oxiplex/AP gel) reduces formation of intrauterine adhesions following hysteroscopic treatment for retained products of conception.

Conditions

  • Asherman Syndrome

Interventions

DRUG

Oxiplex/AP gel

Intrauterine application of Intercoat following hysteroscopy

DRUG

Normal Saline

No intrauterine application of Intercoat following hysteroscopy

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    lead OTHER_GOV

Principal Investigators

  • Moty Pansky, MD · Asaf Harofe MC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-11-30
Completion
2011-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01377779 on ClinicalTrials.gov